ScholarIQanswers from OpenAlex

Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance

PaperCitations, authors & open-access status

Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance have?

ScholarIQcitation count

Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance has 15 citations in the OpenAlex counts ScholarIQ stores.

When was Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance published?

ScholarIQyear

Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance has 2017 year in the ScholarIQ index.

What is the open-access status of Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance?

ScholarIQoa status

Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance has diamond oa status in the ScholarIQ index.

What is the DOI of Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance?

ScholarIQdoi

The DOI for Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance is on the source record.

What is the PMID of Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance?

ScholarIQpmid

The PMID for Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance is on the source record.

What is the OpenAlex record for Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance?

ScholarIQopenalex

The OpenAlex for Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial